Gates Foundation Awards $38M To Takeda Pharmaceuticals To Develop Low-Cost Polio Vaccine
Reuters: Gates Foundation backs Takeda polio vaccine with $38 million grant
“Japan’s Takeda Pharmaceuticals is to get $38 million from the Bill & Melinda Gates Foundation to develop a crucial, low-cost polio vaccine for use in developing countries. … Chris Elias, the Gates Foundation’s head of global development, said the partnership would help ‘ensure that the world has enough vaccine to get the job done and maintain a polio-free world’…” (Kelland, 5/8).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.